Приказ основних података о документу
2-Aryl-3-(6-trifluoromethoxy)benzo[d]thiazole-based thiazolidinone hybrids as potential anti-infective agents: Synthesis, biological evaluation and molecular docking studies
dc.creator | Haroun, Michelyne | |
dc.creator | Tratrat, Christophe | |
dc.creator | Petrou, Anthi | |
dc.creator | Geronikaki, Athina | |
dc.creator | Ivanov, Marija | |
dc.creator | Ćirić, Ana | |
dc.creator | Soković, Marina | |
dc.date.accessioned | 2021-09-02T10:47:40Z | |
dc.date.available | 2900-01-01 | |
dc.date.issued | 2021 | |
dc.identifier.issn | 0960-894X | |
dc.identifier.uri | https://radar.ibiss.bg.ac.rs/handle/123456789/4300 | |
dc.description.abstract | The search for new antimicrobial agents is greater than ever due to the perpetual threat of multidrug resistance in known pathogens and the relentless emergence of new infections. In this manuscript, ten thiazole-based thiazolidinone hybrids bearing a 6-trifluoromethoxy substituent on the benzothiazole core were synthesized and evaluated against a panel of four bacterial strains Salmonella typhimurium, Staphylococcus aureus, Escherichia coli and Listeria monocytogenes and three resistant strains Pseudomonas aeruginosa, E. coli and MRSA. The evaluation of minimum bactericidal and minimum inhibitory concentrations was accomplished by microdilution assay. As reference compounds ampicillin and streptomycin were employed. All compounds displayed antibacterial efficiencies with MBCs/MICs at 0.25-1 mg/mL and 0.12-1 mg/mL respectively while ampicillin displayed MBCs/MICs at 0.15-0.3 mg/mL and at 0.1-0.2 mg/mL respectively. MICs/MBC of streptomycin varied from 0.05 to 0.15 mg/mL and from 0.1 to 0.3 mg/mL respectively. The best overall effect was observed for compound h4, while compound h1 exhibited the highest effective action against E. coli (MIC/MBC 0.12/0.25 mg/ml) among all tested compounds. | sr |
dc.language.iso | en | sr |
dc.publisher | Elsevier | sr |
dc.relation | info:eu-repo/grantAgreement/MESTD/inst-2020/200007/RS// | sr |
dc.relation | Ministry of Education in Saudi Arabia (project number IFT20175) | sr |
dc.rights | restrictedAccess | sr |
dc.source | Bioorganic & Medicinal Chemistry Letters | sr |
dc.subject | Antibacterial | sr |
dc.subject | Thiazolidinone | sr |
dc.subject | Ampicillin | sr |
dc.subject | Benzothiazole | sr |
dc.subject | MurB | sr |
dc.title | 2-Aryl-3-(6-trifluoromethoxy)benzo[d]thiazole-based thiazolidinone hybrids as potential anti-infective agents: Synthesis, biological evaluation and molecular docking studies | sr |
dc.type | article | sr |
dc.rights.license | ARR | sr |
dcterms.abstract | Иванов, Марија; Хароун, Мицхелyне; Тратрат, Цхристопхе; Петроу, Aнтхи; Героникаки, Aтхина; Соковић, Марина; Ћирић, Aна; | |
dc.rights.holder | © 2020 Elsevier Ltd. | sr |
dc.citation.issue | 15 | |
dc.citation.volume | 32 | |
dc.identifier.doi | 10.1016/j.bmcl.2020.127718 | |
dc.identifier.pmid | 33253880 | |
dc.identifier.scopus | 2-s2.0-85097182805 | |
dc.identifier.wos | 000606577400012 | |
dc.citation.apa | Haroun, M., Tratrat, C., Petrou, A., Geronikaki, A., Ivanov, M., Ciric, A., et al. (2021). 2-Aryl-3-(6-trifluoromethoxy)benzo[d]thiazole-based thiazolidinone hybrids as potential anti-infective agents: Synthesis, biological evaluation and molecular docking studies. Bioorganic & Medicinal Chemistry Letters, 32, 127718. | |
dc.citation.vancouver | Haroun M, Tratrat C, Petrou A, Geronikaki A, Ivanov M, Ciric A, Sokovic M. 2-Aryl-3-(6-trifluoromethoxy)benzo[d]thiazole-based thiazolidinone hybrids as potential anti-infective agents: Synthesis, biological evaluation and molecular docking studies. Bioorg Med Chem Lett. 2021;32:127718. | |
dc.citation.spage | 127718 | |
dc.type.version | publishedVersion | sr |
dc.citation.rank | M22 |